Environmental Enteric Dysfunction Clinical Trial
| Verified date | May 2018 |
| Source | Washington University School of Medicine |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Randomized, double-blind, placebo controlled trial of daily lactoferrin and lysozyme supplementation in improving environmental enteric dysfunction in Malawian children
| Status | Completed |
| Enrollment | 235 |
| Est. completion date | December 2017 |
| Est. primary completion date | December 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 12 Months to 35 Months |
| Eligibility |
Inclusion Criteria: - children aged 12-35 months - youngest eligible child in each household Exclusion Criteria: - severe or moderate acute malnutrition - severe chronic illness - children unable to drink 20 mL of dual sugar solution - children in need of acute medical treatment for illness or injury at time of enrollment |
| Country | Name | City | State |
|---|---|---|---|
| Malawi | Malawi | Blantyre |
| Lead Sponsor | Collaborator |
|---|---|
| Washington University School of Medicine | University of Malawi |
Malawi,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Linear Growth | changes in linear growth | 16 weeks | |
| Primary | Dual Sugar Absorption Test | lactulose-mannitol ratio in urine | 8 weeks | |
| Primary | Dual Sugar Absorption Test | lactulose-mannitol ratio in urine | 16 weeks | |
| Secondary | Lactulose Excretion | percentage of ingested lactulose excreted in urine | 8 weeks | |
| Secondary | Lactulose Excretion | percentage of ingested lactulose excreted in urine | 16 weeks | |
| Secondary | Mannitol Excretion | percentage of ingested mannitol excreted in urine | 8 weeks | |
| Secondary | Mannitol Excretion | percentage of ingested mannitol excreted in urine | 16 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT04984447 -
OCT Guided Trans Nasal Imaging of the Small Intestine in Adults
|
N/A | |
| Recruiting |
NCT06002438 -
Eggs for Gut Health
|
N/A | |
| Completed |
NCT03263871 -
PTM202 for the Treatment of Environmental Enteric Dysfunction (EED)
|
N/A | |
| Enrolling by invitation |
NCT04275167 -
Capsule Endomicroscopy for Visualization of the Small Intestine in EED Population in Pakistan
|
N/A | |
| Recruiting |
NCT03313128 -
SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
|
||
| Completed |
NCT02758444 -
Effects of EED on Zn Absorption and Retention in Children From a MNP
|
N/A | |
| Completed |
NCT02760095 -
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
|
||
| Recruiting |
NCT05501470 -
Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal
|
Phase 2 | |
| Recruiting |
NCT06196450 -
Maternal Probiotic Intervention to Improve Gut Health
|
Phase 2 | |
| Completed |
NCT05291559 -
Acceptability and Efficacy of Enterade (VS001) in Children at Risk for Environmental Enteric Dysfunction in Bangladesh
|
N/A | |
| Terminated |
NCT03782272 -
Safety, Acceptability, and Feasibility of Enterade®
|
N/A | |
| Completed |
NCT03801317 -
The Effect of Bovine Colostrum/ Egg Supplementation in Young Malawian Children
|
N/A | |
| Recruiting |
NCT05922683 -
Maternal Probiotic Intervention to Improve Gut Health
|
Phase 2 |